These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10586190)

  • 1. Intravenous immunoglobulin in neonatal myasthenia gravis.
    Bassan H; Spirer Z
    J Pediatr; 1999 Dec; 135(6):790. PubMed ID: 10586190
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose intravenous immunoglobulin in transient neonatal myasthenia gravis.
    Bassan H; Muhlbaur B; Tomer A; Spirer Z
    Pediatr Neurol; 1998 Feb; 18(2):181-3. PubMed ID: 9535308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of intravenously administered immunoglobulin in the treatment of neonatal myasthenia gravis.
    Tagher RJ; Baumann R; Desai N
    J Pediatr; 1999 Feb; 134(2):233-5. PubMed ID: 9931536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulin for myasthenia gravis.
    Gajdos P; Chevret S; Toyka K
    Cochrane Database Syst Rev; 2003; (2):CD002277. PubMed ID: 12804431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient neonatal myasthenia gravis in a baby born to a mother with new-onset anti-MuSK-mediated myasthenia gravis.
    O'carroll P; Bertorini TE; Jacob G; Mitchell CW; Graff J
    J Clin Neuromuscul Dis; 2009 Dec; 11(2):69-71. PubMed ID: 19955986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma exchange and intravenous immunoglobulin in autoimmune myasthenia gravis.
    Gajdos P; Chevret S; Clair B; Tranchant C; Chastang C
    Ann N Y Acad Sci; 1998 May; 841():720-6. PubMed ID: 9668320
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of the effectiveness of intravenous immunoglobulin and plasma exchange as preoperative therapy of myasthenia gravis.
    Jensen P; Bril V
    J Clin Neuromuscul Dis; 2008 Mar; 9(3):352-5. PubMed ID: 18344718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exchange transfusion in neonatal myasthenia gravis.
    Donat JF; Donat JR; Lennon VA
    Neurology; 1981 Jul; 31(7):911-2. PubMed ID: 7195520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards evidence based medicine for paediatricians. Is intravenous immunoglobulin superior to exchange transfusion in the management of hyperbilirubinaemia in term neonates?
    Walsh S; Molloy EJ
    Arch Dis Child; 2009 Sep; 94(9):739-41. PubMed ID: 19700431
    [No Abstract]   [Full Text] [Related]  

  • 10. Experience with intravenous immunoglobulin in myasthenia gravis: a review.
    Edan G; Landgraf F
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57 Suppl(Suppl):55-6. PubMed ID: 7964855
    [No Abstract]   [Full Text] [Related]  

  • 11. Exchange transfusion in neonatal myasthenia.
    Pasternak JF; Hageman J; Adams MA; Philip AG; Gardner TH
    J Pediatr; 1981 Oct; 99(4):644-6. PubMed ID: 7277111
    [No Abstract]   [Full Text] [Related]  

  • 12. [Myasthenia gravis and treatment with intravenous immunoglobulins].
    Rodriguez-Perez JA; Carballoza-Bernal A; Dorta-Contreras AJ
    Rev Neurol; 2016 Nov; 63(9):431-432. PubMed ID: 27779306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transient neonatal myasthenia gravis].
    Váradi V; Nagy A; György I; Machay T; Papp Z
    Orv Hetil; 1995 Feb; 136(8):401-5. PubMed ID: 7885685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aseptic meningitis as a complication of intravenous immunoglobulin therapy for myasthenia gravis.
    Ellis RJ; Swendson MR; Bajorek J
    Muscle Nerve; 1994 Jun; 17(6):683-4. PubMed ID: 8196714
    [No Abstract]   [Full Text] [Related]  

  • 15. [Respective indications of plasma exchange and high-dose immunoglobulins in polyradiculoneuritis and myasthenia gravis].
    Raphaël JC; Annane D; Chevret S; Chillet P; Gajdos P
    Presse Med; 1996 Oct; 25(31):1516-22. PubMed ID: 8958883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immune globulin in myasthenia gravis.
    Gajdos P
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):49-51. PubMed ID: 8033435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin for the treatment of acquired myasthenia gravis.
    Howard JF
    Neurology; 1998 Dec; 51(6 Suppl 5):S30-6. PubMed ID: 9851728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myasthenia gravis: helping patients have better outcomes.
    Weeks BH
    Nurse Pract; 2012 Sep; 37(9):30-6; Quiz 36-7. PubMed ID: 22850535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of therapeutic options used for myasthenia gravis.
    Mandawat A; Kaminski HJ; Cutter G; Katirji B; Alshekhlee A
    Ann Neurol; 2010 Dec; 68(6):797-805. PubMed ID: 21061395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IVIG in myasthenia gravis: getting enough "bang for the buck".
    Meriggioli MN
    Neurology; 2007 Mar; 68(11):803-4. PubMed ID: 17353466
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.